Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Cost-Effectiveness of Rivaroxaban versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in the Guangdong Healthcare Setting in China

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-E-043-Tuesday
  • By: ZHOU, Jing (guangzhou, China)
  • Co-author(s): Jing Zhou: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
    Biyu Huang: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
    Min Yang: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
  • Abstract:

    Backgrounds

    Warfarin has been the mainstay of anticoagulant therapy for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). Rivaroxaban, a novel oral anticoagulant which offers some distinct advantages over warfarin has been introduced.

    Aims

    To evaluate the cost-effectiveness of rivaroxaban versus warfarin for stroke prevention

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses